ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,239.97
0.91%
S&P 500
5,460.48
-0.41%
Dow Jones
39,118.86
-0.12%
US Dollar vs Yen
160.944
0.02%
Brent Oil
85.515
0.48%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Organicell Regenerative Medicine Inc (QB) (OCEL)

  7. Organicell Regenerative Medicine Inc (QB) (OCEL) ニュース

OCEL

Organicell Regenerative ... (QB) (OCEL)

Organicell Regenerative Medicine Inc (QB)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:OCEL
日付受信時刻ニュースソース見出しコード企業名
2023/11/2807 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/11/1506 : 29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/10/1919 : 56Edgar (US Regulatory)Form PRER14C - Information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/09/2903 : 54Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/09/1505 : 15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/08/2604 : 13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/08/1505 : 34Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/08/1005 : 05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/08/0205 : 15Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/07/2622 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/07/1206 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/07/1205 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/07/0105 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/07/0105 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/06/2922 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/06/2922 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/06/2905 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/06/2905 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/06/2121 : 46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/06/1705 : 07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/06/1505 : 02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/06/1005 : 36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/06/1005 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/05/1605 : 10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/05/0205 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/04/2205 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/03/1805 : 17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/03/0906 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/02/1506 : 59Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
2023/02/1506 : 39Edgar (US Regulatory)Annual Report (10-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
 Showing the most relevant articles for your search:USOTC:OCEL

最近閲覧した銘柄

FX
USDEUR
US Dollar vs Euro
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
FX
USDGBP
US Dollar vs Sterling
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
SPI
SP500
S&P 500
NYSE
JPM
JP Morgan Chase
FX
USDJPY
US Dollar vs Yen
CCOM
US30
US 30
PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
NASDAQ
TSLA
Tesla
NYSE
AXP
American Express
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有